| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $18.9M | $21.3M | $20.6M |
| YoY Revenue Growth % | -11.3% | +3.4% | — |
| Gross Profit | $9.5M | $13.9M | — |
| Gross Margin % | 50.4% | 65.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$6.1M | -$2.1M | -$8.7M |
| Operating Margin % | -32.3% | -9.9% | -42.1% |
| Net Income (GAAP) | -$15.2M | -$8.8M | -$10.3M |
| EBITDA (Normalized) | -$5.9M | -$2.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.7M | -$4.0M | -$6.1M |
| Capital Expenditures (CapEx) | $205.4K | $36.3K | — |
| Free Cash Flow (FCF) | -$1.9M | -$4.0M | -$6.1M |
| FCF Margin % | -10.1% | -18.9% | -29.8% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $10.5M | $8.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $4.3M | -$4.6M | — |